Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A narrative reorganization of published single-cell datasets proposing a ranked hypothesis framework for host-directed therapy targets in bacterial pneumonia, without new primary data, validation, or clinical outcome evidence.
Mechanistic study in animal models demonstrating a pathway by which PD-1 blockade may worsen neurodegeneration, but no human clinical evidence or hard endpoints to support direct translation to patient care.
This is an exploratory multi-omics association study using unsupervised clustering to identify molecular subtypes linked to insomnia features in CRC; it raises mechanistic questions and generates a risk score but lacks prospective validation, a comparator arm, or hard clinical outcome data to support causal inference or clinical action.
A comprehensive mechanistic review synthesizing molecular and physiological evidence for cross-talk between two receptor pathways, raising questions about therapeutic translation rather than answering them with clinical evidence.
A comprehensive narrative review synthesizing evidence on geriatric mental disorder pathophysiology, management, and emerging approaches; provides clinical roadmap rather than new primary evidence.
Small single-center animal study with a primary finding (reduced weight gain) that lacks statistical significance testing and ER stress markers showing only numerical, non-significant reductions, requiring confirmation in larger cohorts.
The International Journal of Neuropsychopharmacology
A consensus-based presentation of operational criteria for TRD and PRD, combined with a review of biological mechanisms and trial design innovations, intended to standardize definitions and inform future clinical research rather than report a primary empirical finding.